ALK alumni's start up lands new million-kroner investment

Allero Therapeutics, which consists of former ALK directors Poul Sørensen and Flemming Steen Jensen among others, have landed another million-kroner investment from a Dutch venture fund. The company is counting on an early stage investment round next year.

Poul Sørensen, co-founder and CSO at Allero Therapeutics. Photo: Allero Therapeutics / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles